StockData
Capricor Therapeutics, Inc. logo

Capricor Therapeutics, Inc. (CAPR) stock

CAPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$8.41+0.11 (+1.33%)

Close on Nov 17, 2026Market cap $488.95MP/E –Yield –

Capricor Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Capricor Therapeutics's market cap was $651.98M on Nov 11, 2026, against $244.59M a year earlier. Over the last 5 years it ranged from $70.76M to $1.93B, with a median of $166.95M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$651.98M-50.6%
2025Dec 31, 2025$1.32B+137.1%
2024Dec 31, 2024$556.59M+340.2%
2023Dec 29, 2023$126.43M+32.6%
2022Dec 30, 2022$95.35M+34.8%
2021Dec 31, 2021$70.76M+2.1%
2020Dec 31, 2020$69.33M+1197.3%
2019Dec 31, 2019$5.34M-57.6%
2018Dec 31, 2018$12.61M-68.2%
2017Dec 29, 2017$39.66M-30.3%
2016Dec 30, 2016$56.92M+14.1%
2015Dec 31, 2015$49.90M+13.7%
2014Dec 31, 2014$43.89M+31.9%
2013Dec 31, 2013$33.28M+31.4%
2012Dec 31, 2012$25.33M-90.1%
2011Dec 30, 2011$256.93M–

More Capricor Therapeutics figures

See a number that looks wrong?